UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032813
Receipt number R000037421
Scientific Title The development of nutrition therapy for latter-stage elderly to maintain and improve ADL: multicenter alternative study
Date of disclosure of the study information 2018/06/01
Last modified on 2020/12/02 18:54:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The development of nutrition therapy for latter-stage elderly to maintain and improve ADL: multicenter alternative study

Acronym

The development of nutrition therapy for latter-stage elderly to maintain and improve ADL

Scientific Title

The development of nutrition therapy for latter-stage elderly to maintain and improve ADL: multicenter alternative study

Scientific Title:Acronym

The development of nutrition therapy for latter-stage elderly to maintain and improve ADL

Region

Japan


Condition

Condition

fracture, pneumonia, urinary tract infection, cancer

Classification by specialty

Geriatrics

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to develop the effective and practical method of nutrition treatment which paid attention to ADL maintenance/improvement for latter-stage elderly with lifestyle diseases.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes of the activity of daily living, skeletal muscle mass, muscle strength

Key secondary outcomes

Changes of dietary intakes (energy, protein, vitamin D, etc.), hemoglobin, aspartate aminotransferase, alanine aminotransferase, creatinine, blood urea nitrogen, estimated glomerular filtration rate, serum albumin, c-reactive protein.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Intensive nutrition (energy 25-35 kcal/kgBW, protein 1.5 g/kgBW, vitamin D 10 microg)

Interventions/Control_2

Conventional nutrition (energy 25-35 kcal/kgBW, protein 1.0 g/kgBW)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

75 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)75 years old at the first date of hospitalization
(2) Patients with fracture, pneumonia, urinary tract infection, cancer
(3) Nursing necessary degree of B is less than three points during hospitalization
(4) MNA-Short Form is 8 to 11 points

Key exclusion criteria

(1) Dementia or mental disease
(2) Using steroid
(3) Severe liver and/or renal dysfunction (Child-Pugh classification > 7, Cre > 2 mg/dL)
(4) Heart failure (New York Heart Association class 2, 3, 4)
(5) Severe diabetic complications (nephropathy; stage 3-4, proliferative retinopathy, neuropathy)
(6) Patients with SIRS or AIS score > 4
(7) Patients with the past of the gastrointestinal operation
(8) Cancer which cannot cure radically
(9) Patients with a pacemaker or the shrubbery model defibrillator
(10) Patients who have motor paralysis in their limbs due to neuromuscular disease
(11) Patient who judged that a study enforcement person in charge or a study partaker was unsuitable for this clinical study

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Yutaka
Middle name
Last name Seino

Organization

Kansai Electric Power Hospital

Division name

President

Zip code

553-0003

Address

2-1-7 Fukushima, Fukushima Ward, Osaka 5530003, Japan.

TEL

06-6458-5821

Email

yutaka.seino.hp@gmail.com


Public contact

Name of contact person

1st name Noboru
Middle name
Last name Makabe

Organization

Kansai Electric Power Hospital

Division name

The AMED Seino squad secretariat

Zip code

553-0003

Address

2-1-7 Fukushima, Fukushima Ward, Osaka 5530003, Japan.

TEL

06-6458-5821

Homepage URL


Email

n-makabe@umin.ac.jp


Sponsor or person

Institute

Kansai Electric Power Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Japan Society of Metabolism and Clinical Nutrition

Address

3-13-11 Yotsuya, Shinjuku-ku, Tokyo Sakae Building 5F

Tel

03-5363-2361

Email

jimukyoku@eiyou.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

200

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 04 Month 15 Day

Date of IRB

2018 Year 05 Month 31 Day

Anticipated trial start date

2018 Year 07 Month 01 Day

Last follow-up date

2020 Year 06 Month 30 Day

Date of closure to data entry

2020 Year 07 Month 31 Day

Date trial data considered complete

2020 Year 08 Month 31 Day

Date analysis concluded

2020 Year 11 Month 30 Day


Other

Other related information



Management information

Registered date

2018 Year 05 Month 31 Day

Last modified on

2020 Year 12 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037421


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name